‘Tariffs are a tax on your grocery bill;' Canada places billboard in Ohio amid trade war
Canada is looking to get the attention of Cincinnati residents, originally reported by our news partner WCPO Cincinnati.
A billboard off Norwood Lateral says, 'Tariffs are a tax on your grocery bill.' Then, underneath it says, 'Paid for by the Government of Canada,' according to WCPO.
[DOWNLOAD: Free WHIO-TV News app for alerts as news breaks]
The ad is a response to the Trump administration's trade war with Canada, WCPO says. Trump has called for Canada to become the 51st state, and has also signed an executive order that imposed a 25 percent tariff on imports from Canada and Mexico, and added tariffs for Canadian energy products and steel and aluminum, WCPO says.
TRENDING STORIES:
Risk for severe weather with damaging winds, hail Sunday
Driver 'intentionally' hits man with car, police say
Former 'Bachelorette' star says stage 4 breast cancer has spread to liver
Trump has, on multiple occasions, paused or postponed some of the tariffs on Canada, but tensions remain high. On the same day the billboard was spotted, Trump announced a 25 percent tariff on all non-US made cars starting April 2. Trump has also spoken about plans to add tariffs on lumber, copper and computer chips, WCPO says.
Last week, Canadian Foreign Minister Melanie Joly told CNN Canada would be launching ads about the tariffs near major interstates across 12 states, including Florida, Georgia, Michigan and Ohio, according to WCPO.
'We know very much that these states are red states, but we're doing that because we think we need to send a message to the American people for them to understand what's at stake, because this is really going to hurt their livelihoods and have an impact on their wallets,' Joly said.
Joly is encouraging Americans to contact their legislators and let them know they are against the tariffs.
[SIGN UP: WHIO-TV Daily Headlines Newsletter]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
35 minutes ago
- Business Wire
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success' New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today disclosed that on June 12, 2025, Advantech/Prime Success filed a Petition for Emergency Injunctive Relief against SINOVAC, et al., naming as relief parties Cede & Co., The Depository Trust Company, and Equiniti (the dividend paying agent retained by the SINOVAC Board), which may prevent the SINOVAC Board from paying the US$55.00 special dividend as scheduled on or about July 9, 2025. We learned that Vivo Capital's counsel informed the paying agent that Vivo would challenge the dividend and asked the paying agent to withdraw from facilitating the distribution of the US$55.00 dividend declared by the SINOVAC Board to all valid shareholders. The SINOVAC Board has an obligation to answer this Petition on behalf of all SINOVAC common shareholders to stand up to the egregious actions of Prime Success. We expect to file our Opposition Brief today at 5:00 p.m. Atlantic Standard Time, followed by a hearing on Wednesday, June 18. We continue to be shocked by the self-serving, unnecessary actions by Advantech and Vivo Capital (together known as the 'Dissenting Investor Group') against SINOVAC, threatening the rightful dividend payment to all valid SINOVAC common shareholders. These incomprehensible actions are unacceptable to the SINOVAC Board because: The Dissenting Investor Group has already pocketed more than US$1.1 billion in dividends from SINOVAC's operating subsidiary, while all SINOVAC's valid shareholders received nothing. An amount equal to the aggregate amount of cash that would be payable under the US$55.00 per common share special dividend in respect of the 2018 PIPE shares has been set aside by the SINOVAC Board in an escrow account managed by an independent third party pending final resolution of the legal proceedings, which the Dissenting Investor Group initiated. Thus, there is no risk whatsoever that the Dissenting Investor Group's allocations of the dividend will not be paid if the courts ultimately decide in their favor regarding the PIPE shares. These new actions by the Dissenting Investor Group go against their assertions of their support of the US$55.00 dividend payment in their letters to shareholders and raises the question – how can you trust anything they say in their letters or press releases? The SINOVAC Board will continue to fight these frivolous lawsuits, all of which aim to accomplish one thing: to allow the Dissenting Investor group to double dip on dividends. We feel certain we will prevail quickly in this and other proceedings. The SINOVAC Board is on a mission to restore fairness and deliver value to ALL SINOVAC shareholders. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and relate to events that involve known or unknown risks, uncertainties and other factors, including without limitation risks, uncertainties and factors related to the timing of filings, hearings and other litigation-related matters, all of which are difficult to predict and many of which are beyond the Company's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Yahoo
40 minutes ago
- Yahoo
Morning Bid: Markets in wait-and-see mode on Mideast
A look at the day ahead in European and global markets from Wayne Cole. While Israel and Iran continue to exchange missiles, markets have been resilient so far on Monday with most Asian indexes in the black. Chinese retail sales topped forecasts, but to no discernible reaction. Oil jumped 4% at the open, but soon calmed down and is now up around 1%. Given the region's history, war in the Middle East is not surprising and, so far, this one does not look like spreading wider. Crucially, investors seem to be assuming Iran will not threaten to close the Strait of Hormuz since that would risk dragging the United States into the conflict. There's also plenty of scope for Saudi Arabia and the rest of OPEC to expand supply if needed to keep prices restrained. The escalation is certainly an unwanted headache for the G7 meeting in Canada, which faces more than enough confrontation ahead over President Trump's tariffs on allies. There has been little sign of concrete progress on any trade deals, and even last week's U.S.-China tariff truce might not have fixed the restrictions on minerals most closely tied to national security. The spike in oil will be an added complication for the Federal Reserve meeting this week, but it would have to be a sustained rise in prices to be a true inflationary threat. A steady outcome on rates is considered a done deal with the real focus on whether the Fed's dot plots keep two cuts for this year, or scale back to just one as some suspect. It's a busy week for central banks in general, with the Bank of Japan expected to stand pat on Tuesday but maybe signal a slowdown in its bond tapering for next year. The Bank of England and Norges Bank are also seen holding steady, while the Riksbank is likely to cut. Markets are fully priced for a quarter point easing to zero from the Swiss National Bank, with a good chance of going negative given the strength of the franc. Key developments that could influence markets on Monday: - Appearances by ECB members Joachim Nagel and Piero Cipollone
Boston Globe
an hour ago
- Boston Globe
The Group of Seven summit is opening in Canada with a focus on trade, wars — and not riling Trump
'I have instructed our U.S. Reps not to endorse the Communique as we look at Tariffs on automobiles flooding the U.S. Market!' Trump posted on the site then known as Twitter. This time, Trump already has hit several dozen nations with severe tariffs that risk a global economic slowdown. There is little progress on settling the wars in Ukraine and Gaza and now a new and escalating conflict between Israel and Iran over Tehran's nuclear program. Advertisement Add to all of that the problems of climate change, immigration, drug trafficking, new technologies such as artificial intelligence and China's continued manufacturing superiority and chokehold on key supply chains. Asked if he planned to announce any trade agreements at the G7 as he left the White House on Sunday, Trump said: 'We have our trade deals. All we have to do is send a letter, 'This is what you're going to have to pay.' But I think we'll have a few, few new trade deals.' Advertisement At stake might be the survival of the G7 itself at a time when the Trump administration has sent mixed signals about whether the president will attend the November Group of 20 summit in South Africa. What Trump opposed at the 2018 summit in Quebec wasn't just tariffs, but a focus on having alliances with a shared set of standards seeking to shape policies. 'The big dispute in Quebec were the references to the rules-based international order and that's where that famous photo comes from,' said Peter Boehm, Canada's counselor at the 2018 G7 summit in Quebec and a veteran of six G7 summits. 'I think it gave everyone the idea that G7s were maybe not business as usual.' The German, U.K., Japanese and Italian governments have each signaled a belief that a friendly relationship with Trump this year can reduce the likelihood of outbursts. 'Well, I have got a good relationship with President Trump, and that's important,' U.K. Prime Minister Keir Starmer said Saturday as he flew to Canada. There is no plan for a joint statement this year from the G7, a sign that the Trump administration sees no need to build a shared consensus with fellow democracies if it views such a statement as contrary to its goals of new tariffs, more fossil fuel production and a Europe that is less dependent on the U.S. military. 'The Trump administration almost certainly believes that no deal is better than a bad deal,' said Caitlin Welsh, a director at the Center for Strategic and International Studies think tank who was part of Trump's team for the G7 in Trump's first term. Advertisement The White House has stayed decidedly mum about its goals for the G7, which originated as a 1973 finance ministers' meeting to address the oil crisis and steadily evolved into a yearly summit that is meant to foster personal relationships among world leaders and address global problems. The G7 even briefly expanded to the G8 with Russia as a member, only for Russia to be expelled in 2014 after annexing Crimea and taking a foothold in Ukraine that preceded its aggressive 2022 invasion of that nation. Trump will have at least three scheduled bilateral meetings during the summit with other world leaders while in Canada, staring on Monday morning with Canadian Prime Minister Mark Carney. The U.S. president is also expected to have bilateral meetings with Mexican President Claudia Sheinbaum and Ukrainian President Volodymyr Zelenskyy, according to an administration official. The U.S. president has imposed 25% tariffs on steel, aluminum and autos, all of which have disproportionately hit Japan. Trump is also charging a 10% tax on imports from most countries, though he could raise rates on July 9, after the 90-day negotiating period set by him would expire. The United Kingdom reached a trade framework with the U.S. that included quotas to protect against some tariffs, but the 10% baseline would remain as the Trump administration is banking on tariff revenues to help cover the cost of its income tax cuts. Canada and Mexico face separate tariffs of as much as 25% that Trump put into place under the auspices of stopping fentanyl smuggling, through some products are still protected under the 2020 U.S.-Mexico-Canada Agreement signed during Trump's first term. Advertisement The Trump administration has insisted that its broad tariffs will produce trade agreements that box out China, though it's unclear how antagonizing trade partners would make them want to strengthen their reliance on the U.S. Carney, the Canadian leader, has been outspoken in saying his country can no longer look to the U.S. as an enduring friend. That might leave Trump with the awkward task of wanting to keep his tariffs in place while also trying to convince other countries that they're better off siding with the U.S. than China. 'Trump will try to coordinate the group against China's economic coercion,' Josh Lipsky, chair of international economics at the Atlantic Council, wrote in an analysis. 'But the rest of the leaders may turn back to Trump and say that this kind of coordination, which is at the heart of why the G7 works, would be easier if he weren't imposing tariffs on his allies.' Boak reported from Calgary, Alberta. Associated Press writer Jill Lawless contributed to this report.
